Praxis Precision Medicines Ownership 2024 | Who Owns Praxis Precision Medicines Now?

Overview Forecast RevenueFinancials Chart

Institutional Ownership

0.34%

Insider Ownership

0.26%

Retail Ownership

99.40%

Institutional Holders

2.00

Praxis Precision Medicines Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
BAKER BROS. ADVISORS LP	-	-	-	-131,533	-100.00%	-	Mar 31, 2024
SPHERA FUNDS MANAGEMENT LTD.	-	-	-	-328,986	-100.00%	-	Mar 31, 2024

Praxis Precision Medicines's largest institutional shareholder is BAKER BROS. ADVISORS LP, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
BAKER BROS. ADVISORS LP	-	-	-	-131,533	-100.00%	-	Mar 31, 2024
SPHERA FUNDS MANAGEMENT LTD.	-	-	-	-328,986	-100.00%	-	Mar 31, 2024

The largest Praxis Precision Medicines shareholder by % of total assets is BAKER BROS. ADVISORS LP. The company owns 0.00 shares of Praxis Precision Medicines (PRAX), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
BAKER BROS. ADVISORS LP	-	-	-	-131,533	-100.00%	-	Mar 31, 2024
SPHERA FUNDS MANAGEMENT LTD.	-	-	-	-328,986	-100.00%	-	Mar 31, 2024

As of Mar 31 2024, Praxis Precision Medicines's largest institutional buyer is BAKER BROS. ADVISORS LP. The company purchased -0.13M stocks of PRAX, valued at -.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SPHERA FUNDS MANAGEMENT LTD.	-	-	-	-328,986	-100.00%	-	Mar 31, 2024
BAKER BROS. ADVISORS LP	-	-	-	-131,533	-100.00%	-	Mar 31, 2024

As of Mar 31 2024, Praxis Precision Medicines's biggest institutional seller is SPHERA FUNDS MANAGEMENT LTD.. The company sold -0.33M shares of PRAX, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SPHERA FUNDS MANAGEMENT LTD.	-	-	-	-328,986	-100.00%	-	Mar 31, 2024
BAKER BROS. ADVISORS LP	-	-	-	-131,533	-100.00%	-	Mar 31, 2024

Praxis Precision Medicines's largest sold out institutional shareholder by shares sold is SPHERA FUNDS MANAGEMENT LTD., sold -0.33M shares, valued at -, as of undefined.

Praxis Precision Medicines Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
CORNERCAP GROUP OF FUNDS /VA/	0.52%	37,838	28,001	284.65%	Sep 30, 2022
Federated Hermes MDT Series	0.15%	360,562	-	-	Jan 31, 2024
VANGUARD VALLEY FORGE FUNDS	0.14%	73,867	-	-	Mar 31, 2024
BRIDGEWAY FUNDS INC	0.08%	190,000	-	-	Mar 28, 2024
PRUDENTIAL SECTOR FUNDS, INC.	0.07%	141,506	-	-	Feb 29, 2024
BlackRock Health Sciences Trust II	0.06%	165,634	-	-	Mar 31, 2024
TEKLA HEALTHCARE INVESTORS	0.06%	51,406	-	-	Mar 31, 2024
TEKLA LIFE SCIENCES INVESTORS	0.05%	23,594	-	-	Mar 31, 2024
AB CAP FUND, INC.	0.04%	1,357,304	-	-	Jan 31, 2024
FIDELITY ADVISOR SERIES VII	0.02%	209,600	-	-	Jan 31, 2024
FIDELITY MT VERNON STREET TRUST	0.02%	470,166	-	-	Feb 29, 2024
Humankind Benefit Corp	0.02%	360	-	-	Dec 31, 2023
FIDELITY SELECT PORTFOLIOS	0.02%	982,929	-	-	Feb 29, 2024
VANGUARD INDEX FUNDS	0.01%	5,331,633	-	-	Mar 31, 2024
FRANKLIN STRATEGIC SERIES	0.01%	103,600	-	-	Jan 31, 2024
QUANTITATIVE MASTER SERIES LLC	0.01%	63,406	-	-	Mar 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS	0.01%	5,162	-	-	Mar 31, 2024
BRIDGEWAY FUNDS INC	0.01%	20,373	-	-	Mar 28, 2024
ETFis Series Trust I	0.01%	8,515	-	-	Jan 31, 2024
GOLDMAN SACHS VARIABLE INSURANCE TRUST	0.01%	22,610	-	-	Mar 31, 2024
Nushares ETF Trust	0.01%	38,648	-	-	Jan 31, 2024
JANUS INVESTMENT FUND	0.00%	1,173,845	-	-	Dec 31, 2023
AB VARIABLE PRODUCTS SERIES FUND, INC.	0.00%	16,180	-	-	Mar 31, 2024
ALPS ETF Trust	0.00%	44,029	-	-	Feb 29, 2024
FINANCIAL INVESTORS TRUST	0.00%	275,000	-	-	Jan 31, 2024
TIAA SEPARATE ACCOUNT VA 1	0.00%	684	-	-	Mar 31, 2024
FIDELITY COMMONWEALTH TRUST	0.00%	9,700	-	-	Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	88,154	-	-	Mar 31, 2024
Principal Exchange-Traded Funds	0.00%	34,652	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	477,044	-	-	Feb 29, 2024
Direxion Shares ETF Trust	0.00%	316,695	-	-	Jan 31, 2024
Fidelity Commonwealth Trust II	0.00%	12,843	-	-	Aug 31, 2023
Managed Portfolio Series	0.00%	37,838	-	-	Jan 31, 2024
DRIEHAUS MUTUAL FUNDS	0.00%	14,093	14,093	-	Mar 28, 2024
T. Rowe Price Index Trust, Inc.	0.00%	34,419	-	-	Feb 29, 2024
BlackRock ETF Trust	0.00%	937	-	-	Jan 31, 2024
FIDELITY COVINGTON TRUST	0.00%	19,055	-	-	Jan 31, 2024
Calvert Variable Products, Inc.	0.00%	2,483	-	-	Mar 31, 2024
OHIO NATIONAL FUND INC	0.00%	17,540	-	-	Mar 31, 2024
MUTUAL FUND SERIES TRUST	0.00%	3,518,062	-	-	Mar 31, 2024
Voya VARIABLE PORTFOLIOS INC	0.00%	19,216	-	-	Mar 31, 2024
SCHWAB CAPITAL TRUST	0.00%	21,152	-	-	Feb 29, 2024
HC CAPITAL TRUST	0.00%	13,580	-	-	Mar 31, 2024
NATIONWIDE VARIABLE INSURANCE TRUST	0.00%	54,386	-	-	Mar 31, 2024
VANGUARD WORLD FUND	0.00%	72,696	-	-	Feb 29, 2024
SCHWAB STRATEGIC TRUST	0.00%	156,895	-	-	Feb 29, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC	0.00%	1,064	-	-	Mar 31, 2024
TIAA-CREF LIFE FUNDS	0.00%	590	-	-	Mar 31, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST	0.00%	14,100	-	-	Mar 31, 2024
Dimensional ETF Trust	0.00%	75,765	-	-	Jan 31, 2024
VARIABLE INSURANCE PRODUCTS FUND II	0.00%	1,836	-	-	Mar 31, 2024
NORTHERN FUNDS	0.00%	17,051	-	-	Mar 28, 2024
SPDR SERIES TRUST	0.00%	4,329,429	-	-	Mar 31, 2024
Blackstone Alternative Investment Funds	0.00%	6,300	-3,300	-34.38%	Mar 31, 2023
SCHWAB CAPITAL TRUST	0.00%	4,126	4,126	-	Jan 31, 2024
FIDELITY SALEM STREET TRUST	0.00%	399,501	-	-	Mar 31, 2024
GOLDMAN SACHS TRUST	0.00%	341,825	-	-	Mar 31, 2024
RYDEX SERIES FUNDS	0.00%	362	-	-	Dec 31, 2023
VANGUARD SCOTTSDALE FUNDS	0.00%	170,116	-	-	Feb 29, 2024
RBB FUND, INC.	0.00%	7,893	7,893	-	Feb 29, 2024
USAA MUTUAL FUNDS TRUST	0.00%	15,597	15,597	-	Jan 31, 2024
VALIC Co I	0.00%	17,554	-	-	Feb 29, 2024
RBB FUND, INC.	0.00%	5,572	-	-	Feb 29, 2024
AMERICAN CENTURY ETF TRUST	0.00%	6,538	-	-	Feb 29, 2024
USAA MUTUAL FUNDS TRUST	0.00%	12,568	-	-	Jan 31, 2024
ProFunds	0.00%	604	-	-	Mar 31, 2024
SEI INSTITUTIONAL MANAGED TRUST	0.00%	141,700	-	-	Dec 31, 2023
COLLEGE RETIREMENT EQUITIES FUND	0.00%	48,974	-	-	Mar 31, 2024
PENN SERIES FUNDS INC	0.00%	1,200	-	-	Mar 28, 2024
RYDEX DYNAMIC FUNDS	0.00%	159	-	-	Dec 31, 2023
AMERICAN CENTURY ETF TRUST	0.00%	4,094	4,094	-	Feb 29, 2024
TIAA-CREF FUNDS	0.00%	103,060	-	-	Mar 31, 2024
Guggenheim Active Allocation Fund	0.00%	194	-	-	Feb 29, 2024
VANGUARD WELLINGTON FUND	0.00%	11,021	-	-	Feb 29, 2024
RUSSELL INVESTMENT CO	0.00%	8,100	-	-	Jan 31, 2024
PACE SELECT ADVISORS TRUST	0.00%	8,500	-	-	Jan 31, 2024
NATIONWIDE MUTUAL FUNDS	0.00%	3,440	-	-	Jan 31, 2024
J.P. Morgan Exchange-Traded Fund Trust	0.00%	10,889	-	-	Jan 31, 2024
PROSHARES TRUST	0.00%	5,639	-	-	Feb 29, 2024
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	20,664	-	-	Jan 31, 2024
Dimensional ETF Trust	0.00%	8,782	8,782	-	Jan 31, 2024
RYDEX VARIABLE TRUST	0.00%	22	-	-	Dec 31, 2023
PGIM ETF TRUST	0.00%	1,231	-	-	Feb 29, 2024
EQ ADVISORS TRUST	0.00%	21,170	-	-	Mar 31, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST	0.00%	42,342	-	-	Mar 31, 2024
iSHARES TRUST	0.00%	262,499	-	-	Mar 31, 2024
SUNAMERICA SERIES TRUST	0.00%	5,465	-	-	Mar 31, 2024
Brighthouse Funds Trust II	0.00%	13,093	-	-	Mar 31, 2024
SPDR INDEX SHARES FUNDS	0.00%	2,329	-	-	Mar 31, 2024
COLUMBIA FUNDS SERIES TRUST I	0.00%	54,688	-	-	Feb 29, 2024
MORGAN STANLEY PATHWAY FUNDS	0.00%	1,097	-	-	Feb 29, 2024
ETF Series Solutions	0.00%	189	-	-	Jan 31, 2024
NORTHERN FUNDS	0.00%	1,136	-	-	Mar 28, 2024
Franklin Alternative Strategies Funds	0.00%	4,216	-	-	Feb 29, 2024
WILSHIRE MUTUAL FUNDS INC	0.00%	2,279	-	-	Dec 31, 2023
Franklin Alternative Strategies Funds	0.00%	3,716	-	-	Feb 29, 2024
SEI INSTITUTIONAL INVESTMENTS TRUST	0.00%	135,319	-	-	Feb 29, 2024
NATIONWIDE MUTUAL FUNDS	0.00%	554	554	-	Jan 31, 2024
Invesco Exchange-Traded Fund Trust II	0.00%	845	-	-	Jan 31, 2024
Bridge Builder Trust	0.00%	12,187	-	-	Mar 31, 2024

Praxis Precision Medicines's largest mutual fund holder by % of total assets is "CORNERCAP GROUP OF FUNDS /VA/", owning 37.84K shares, compromising 0.52% of its total assets.

Praxis Precision Medicines Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Dec, 23	2	-97.37%
30 Sep, 23	76	-1.30%
30 Jun, 23	77	-13.48%
31 Mar, 23	89	-15.24%
31 Dec, 22	105	-
30 Sep, 22	105	6.06%
30 Jun, 22	99	-3.88%
31 Mar, 22	103	4.04%
31 Dec, 21	99	3.13%
30 Sep, 21	96	18.52%
30 Jun, 21	81	19.12%
31 Mar, 21	68	-1.45%
31 Dec, 20	69	-

As of 31 Dec 23, 2 institutions are holding Praxis Precision Medicines's shares, representing a decrease of -97.37% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Dec, 23	460,519	-99.60%
30 Sep, 23	114,399,484	-2.21%
30 Jun, 23	116,984,506	119.92%
31 Mar, 23	53,194,904	16.78%
31 Dec, 22	45,551,342	8.28%
30 Sep, 22	42,067,277	-2.43%
30 Jun, 22	43,114,530	-5.06%
31 Mar, 22	45,410,123	3.68%
31 Dec, 21	43,796,533	2.23%
30 Sep, 21	42,839,658	4.04%
30 Jun, 21	41,175,054	12.42%
31 Mar, 21	36,626,237	1.17%
31 Dec, 20	36,202,782	-

Praxis Precision Medicines (PRAX) has 460.52K shares outstanding as of 31 Dec 23, down -99.60% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Dec, 23	0.34%	0.00%
30 Sep, 23	164.04%	0.34%
30 Jun, 23	220.30%	2.20%
31 Mar, 23	100.17%	1.03%
31 Dec, 22	98.82%	1.17%
30 Sep, 22	91.90%	1.03%
30 Jun, 22	94.67%	0.95%
31 Mar, 22	99.90%	1.05%
31 Dec, 21	97.40%	1.06%
30 Sep, 21	95.81%	0.98%
30 Jun, 21	99.05%	1.09%
31 Mar, 21	95.21%	1.06%
31 Dec, 20	94.60%	-

As of 31 Dec 23, Praxis Precision Medicines is held by 0.34% institutional shareholders, representing a 0.00% growth compared to 30 Sep 23.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Dec, 23	-	-100.00%
30 Sep, 23	33	-13.16%
30 Jun, 23	38	-25.49%
31 Mar, 23	51	8.51%
31 Dec, 22	47	-9.62%
30 Sep, 22	52	-17.46%
30 Jun, 22	63	18.87%
31 Mar, 22	53	-13.11%
31 Dec, 21	61	3.39%
30 Sep, 21	59	-7.81%
30 Jun, 21	64	77.78%
31 Mar, 21	36	-47.83%
31 Dec, 20	69	-

- institutional shareholders have increased their position in PRAX stock as of 31 Dec 23 compared to 33 in the previous quarter (a -100.00% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Dec, 23	2	-90.00%
30 Sep, 23	20	-20.00%
30 Jun, 23	25	25.00%
31 Mar, 23	20	-47.37%
31 Dec, 22	38	18.75%
30 Sep, 22	32	60.00%
30 Jun, 22	20	-16.67%
31 Mar, 22	24	60.00%
31 Dec, 21	15	-16.67%
30 Sep, 21	18	80.00%
30 Jun, 21	10	-33.33%
31 Mar, 21	15	-
31 Dec, 20	-	-

2 institutional shareholders have reduced their position in PRAX stock as of 31 Dec 23 compared to 20 in the previous quarter (a -90.00% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Dec, 23	2	-97.37%	460,519	-99.60%	0.34%	0.00%	-	-100.00%	2	-90.00%
30 Sep, 23	76	-1.30%	114,399,484	-2.21%	164.04%	0.34%	33	-13.16%	20	-20.00%
30 Jun, 23	77	-13.48%	116,984,506	119.92%	220.30%	2.20%	38	-25.49%	25	25.00%
31 Mar, 23	89	-15.24%	53,194,904	16.78%	100.17%	1.03%	51	8.51%	20	-47.37%
31 Dec, 22	105	-	45,551,342	8.28%	98.82%	1.17%	47	-9.62%	38	18.75%
30 Sep, 22	105	6.06%	42,067,277	-2.43%	91.90%	1.03%	52	-17.46%	32	60.00%
30 Jun, 22	99	-3.88%	43,114,530	-5.06%	94.67%	0.95%	63	18.87%	20	-16.67%
31 Mar, 22	103	4.04%	45,410,123	3.68%	99.90%	1.05%	53	-13.11%	24	60.00%
31 Dec, 21	99	3.13%	43,796,533	2.23%	97.40%	1.06%	61	3.39%	15	-16.67%
30 Sep, 21	96	18.52%	42,839,658	4.04%	95.81%	0.98%	59	-7.81%	18	80.00%
30 Jun, 21	81	19.12%	41,175,054	12.42%	99.05%	1.09%	64	77.78%	10	-33.33%
31 Mar, 21	68	-1.45%	36,626,237	1.17%	95.21%	1.06%	36	-47.83%	15	-
31 Dec, 20	69	-	36,202,782	-	94.60%	-	69	-	-	-

Praxis Precision Medicines Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Feb 14, 2024	Mastrocola Lauren	officer	Principal Accounting Officer	F-InKind	Sell	48	$44.65	$2.14K	1,927
Feb 14, 2024	Nemiroff Alex	officer	General Counsel and Secretary	F-InKind	Sell	51	$44.65	$2.28K	3,157
Feb 14, 2024	Souza Marcio	director, officer	Chief Executive Officer	F-InKind	Sell	271	$44.65	$12.10K	15,176

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jul 31, 2024	Souza Marcio	director, officer	Chief Executive Officer	A-Award	Buy	185,000	$56.94	$10.53M	185,000
Jul 31, 2024	Nemiroff Alex	officer	General Counsel and Secretary	A-Award	Buy	36,400	$56.94	$2.07M	36,400
Jul 31, 2024	Nemiroff Alex	officer	General Counsel and Secretary	A-Award	Buy	7,800	-	-	10,957
Jul 31, 2024	Mastrocola Lauren	officer	Principal Accounting Officer	A-Award	Buy	21,000	$56.94	$1.20M	21,000
Jul 31, 2024	Mastrocola Lauren	officer	Principal Accounting Officer	A-Award	Buy	4,500	-	-	6,427
Jul 31, 2024	Kelly Timothy Edwin	officer	Chief Financial Officer	A-Award	Buy	36,400	$56.94	$2.07M	36,400
Jul 31, 2024	Kelly Timothy Edwin	officer	Chief Financial Officer	A-Award	Buy	7,800	-	-	12,140
Jun 06, 2024	DeSimone Jill	director	-	A-Award	Buy	8,566	$44.25	$379.05K	8,566
Jun 06, 2024	MITCHELL DEAN J	director	-	A-Award	Buy	8,566	$44.25	$379.05K	8,566
Jun 06, 2024	Chodakewitz Jeffrey	director	-	A-Award	Buy	8,566	$44.25	$379.05K	8,566
Jun 06, 2024	Cudkowicz Merit Ester	director	-	A-Award	Buy	8,566	$44.25	$379.05K	8,566
Jun 06, 2024	YOUNG WILLIAM D	director	-	A-Award	Buy	8,566	$44.25	$379.05K	8,566
Jun 06, 2024	Norden Gregory	director	-	A-Award	Buy	8,566	$44.25	$379.05K	8,566
May 20, 2024	Kelly Timothy Edwin	officer	Chief Financial Officer	A-Award	Buy	606	$12.37	$7.50K	4,340
May 20, 2024	Souza Marcio	director, officer	Chief Executive Officer	A-Award	Buy	1,718	$12.37	$21.25K	16,894
Feb 14, 2024	Mastrocola Lauren	officer	Principal Accounting Officer	F-InKind	Sell	48	$44.65	$2.14K	1,927
Feb 14, 2024	Nemiroff Alex	officer	General Counsel and Secretary	F-InKind	Sell	51	$44.65	$2.28K	3,157
Feb 14, 2024	Souza Marcio	director, officer	Chief Executive Officer	F-InKind	Sell	271	$44.65	$12.10K	15,176
Jan 17, 2024	Kelly Timothy Edwin	officer	Chief Financial Officer	A-Award	Buy	30,000	$43.37	$1.30M	30,000
Jan 17, 2024	Souza Marcio	director, officer	Chief Executive Officer	A-Award	Buy	100,000	$43.37	$4.34M	100,000

The last insider sell of Praxis Precision Medicines's stock was made by Mastrocola Lauren on Feb 14 2024, selling 48 shares at $44.65 per share (valued at $2.14K).

Praxis Precision Medicines Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2024	7	-	-
Q2 2024	8	-	-
Q1 2024	4	7	57.14%
Q4 2023	1	-	-
Q2 2023	10	-	-
Q1 2023	14	8	175.00%
Q4 2022	3	-	-
Q2 2022	25	-	-
Q1 2022	12	4	300.00%
Q4 2021	-	3	-
Q3 2021	2	8	25.00%
Q2 2021	9	1	900.00%
Q1 2021	11	1	1100.00%
Q4 2020	19	52	36.54%
Q4 2019	-	1	-

7 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Praxis Precision Medicines's insiders, as of Q3 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2024	-	-	-
Q2 2024	-	-	-
Q1 2024	-	-	-
Q4 2023	1	-	-
Q2 2023	1	-	-
Q1 2023	5	-	-
Q4 2022	-	-	-
Q2 2022	5	-	-
Q1 2022	-	-	-
Q4 2021	-	3	-
Q3 2021	2	8	25.00%
Q2 2021	-	-	-
Q1 2021	-	-	-
Q4 2020	2	-	-
Q4 2019	-	-	-

As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Praxis Precision Medicines's stocks.

Praxis Precision Medicines Peer Ownership

Ticker	Company
PMVP	PMV Pharmaceuticals, Inc.
CGEM	Cullinan Oncology, Inc.
DYN	Dyne Therapeutics, Inc.
RVMD	Revolution Medicines, Inc. Warrant
MLYS	Mineralys Therapeutics, Inc.
EWTX	Edgewise Therapeutics, Inc.
STOK	Stoke Therapeutics, Inc.
ANTX	AN2 Therapeutics, Inc.
HCWB	HCW Biologics Inc.
CRNX	Crinetics Pharmaceuticals, Inc.
PHVS	Pharvaris N.V.
IMRX	Immuneering Corporation
PEPG	PepGen Inc.
ANEB	Anebulo Pharmaceuticals, Inc.
MOLN	Molecular Partners AG
ELVN	Enliven Therapeutics, Inc.
ELYM	Eliem Therapeutics, Inc.

PRAX Ownership FAQ

Who Owns Praxis Precision Medicines?

Praxis Precision Medicines is owned by institutional shareholders (0.34%), insiders (0.26%), and public (99.40%). The largest institutional shareholder of Praxis Precision Medicines is BAKER BROS. ADVISORS LP (0% of total shares) and the top mutual fund owner is CORNERCAP GROUP OF FUNDS /VA/ (0.52% of total shares).

Who are the major institutional shareholders of Praxis Precision Medicines?

Praxis Precision Medicines's major institutional shareholders are BAKER BROS. ADVISORS LP, and SPHERA FUNDS MANAGEMENT LTD.. The top five shareholders own together 0% of the company's share outstanding.

How many Praxis Precision Medicines shareholders are there?

As of Dec 2023, there are 2 institutional shareholders of Praxis Precision Medicines.

What percentage of Praxis Precision Medicines is owned by BAKER BROS. ADVISORS LP?

BAKER BROS. ADVISORS LP owns 0 shares of Praxis Precision Medicines, representing 0% of the company's total shares outstanding, valued at $0 (as of Mar 2024).

What percentage of Praxis Precision Medicines is owned by SPHERA FUNDS MANAGEMENT LTD?

As of Mar 2024, SPHERA FUNDS MANAGEMENT LTD holds 0 shares of Praxis Precision Medicines (PRAX), compromising 0% of the company, valued at $0.